Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection
- Ecuador-COVID19 Consortium
- , Genotype to Phenotype Japan (G2P-Japan) Consortium
- The University of Tokyo
- Universidad San Francisco de Quito
- Kyoto University
- Tokai University
- Chiba University
- Hiroshima University
- Hokkaido University
- Kumamoto University
- University of Miyazaki
- Laboratorio INTERLAB
- National Institute of Infectious Diseases
- Tokyo Metropolitan Institute of Public Health
- Universidad Internacional del Ecuador
- Dr. Marco Albuja Centros Médicos
- Japan Science and Technology Agency
Producción científica: Contribución a una revista › Artículo › revisión exhaustiva
14
Citas
(Scopus)